(Q35602672)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Cancer vaccines entering Phase III clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

main subject

phase III clinical trial

0 references

author

Ian Spendlove

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

L G Durrant

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Emerging Drugs

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

489-500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

Histamine dihydrochloride and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

Interleukin-2 and histamine dihydrochloride in metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

Neutropenia and neoplasia: an overview of the pharmacoeconomics of sargramostim in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

HSPPC-96: a personalised cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

Carbohydrate antigens as targets for active specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

An autologous oral DNA vaccine protects against murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.489

21 January 2018

Identifiers

DOI

10.1517/14728214.8.2.489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14662001%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference